It has been previously established that a bulbar relay plays an important role in descending inhibition of spinal dorsal horn nociceptive neurons and nociceptive reflexes produced by stimulation in the midbrain periaqueductal gray (PAG). In the present study, selected receptor antagonists were microinjected into the medial medullary nucleus raphe magnus (NRM) to determine whether descending inhibition of the tail flick (TF) reflex in the rat produced by focal electrical stimulation in the midbrain PAG was mediated by serotonin, opioid, or glutamate receptors on bulbospinal neurons in the NRM.
It has been previously established that a bulbar relay plays an important role in descending inhibition of spinal dorsal horn nociceptive neurons and nociceptive reflexes produced by stimulation in the midbrain periaqueductal gray (PAG). In the present study, selected receptor antagonists were microinjected into the medial medullary nucleus raphe magnus (NRM) to determine whether descending inhibition of the tail flick (TF) reflex in the rat produced by focal electrical stimulation in the midbrain PAG was mediated by serotonin, opioid, or glutamate receptors on bulbospinal neurons in the NRM.
It was determined in initial experiments that the serotonin receptor antagonist methysergide, the opioid receptor antagonist naloxone, the local anesthetic lidocaine, and the glutamate receptor antagonists r-D-glutamylglycine (DGG) and DL-2-amino-S-phosphonovalerate (APV) microinjected into the medulla all significantly increased the threshold of focal electrical stimulation in the medulla required to inhibit the TF reflex. The antinociceptive efficacy of agonists at opioid, serotonin, and glutamate receptors was also tested in other experiments. The microinjection of morphine (2.5-10 pg) into the NRM increased significantly TF latencies in a dose-dependent manner in rats in the awake or lightly anesthetized state; morphine was more potent in awake rats. Inhibition of the TF reflex produced by the microinjection of morphine was reversed by a subsequent microinjection of naloxone into the same site in the medulla. The microinjection of serotonin (5 and 10 pg), however, did not affect the latency of the TF reflex in either awake or lightly anesthetized rats. Glutamate (100 mM, 0.5 ~1) microinjected into the rostra1 ventral medulla produced an inhibition of the TF reflex of short duration that could be blocked or attenuated significantly by the glutamate receptor antagonists DGG or APV microinjected into the same site.
In subsequent experiments, a nonspecific functional block was introduced adjacent to the NRM bilaterally in the medullary reticular formations (MRFs) by the microinjection of the local anesthetic lidocaine; receptor antagonists were then microinjetted into the NRM and their effect on the threshold of focal electrical stimulation in the PAG to inhibit the TF reflex determined. No increase was seen in stimulation thresholds in the PAG following the microinjection of either methysergide or naloxone into the NRM. Following the microinjection of lidocaine, DGG or APV into the NRM, the stimulation threshold in the PAG for inhibition of the TF reflex was increased significantly.
The organization in the brain stem of descending systems of spinal inhibition has been the focus of many investigations. Focal electric stimulation in the midbrain periaqueductal gray (PAG), as well as the medullaq nucleus raphe magnus (NRM), has been shown to produce an antinociception-i.e., stimulation-produced antinociception, or SPA (Besson et al., 1981; Mayer and Price, 1976; and citations in Sandkiihler and Gebhart, 1984a )-and to also inhibit the noxious-evoked excitation of spinal dorsal horn neurons (Gebhart, 1986; Willis, 1982) . Similarly, the microinjection of morphine into the PAG or NRM is antinociceptive (Gebhart, 1982; Yaksh and Rudy, 1978) and inhibits spinal dorsal horn nociceptive neurons (Bennett and Mayer, 1979; Clark et al., 1983; Du et al., 1984; Gebhart et al., 1984) . Since there are few direct spinopetal efferents from the PAG (Ruda, 1976; see, however, Mantyh and Peschanski, 1982) , a bulbar relay, proposed initially to be the NRM (Basbaum and Fields, 1978; Fields and Basbaum, 1978) , is interposed between the midbrain PAG and the spinal cord.
While physiological and anatomical studies suggest that the NRM serves as a bulbar relay between the PAG and spinal cord, recent evidence supports the involvement of the laterally adjacent medullary reticular formation (MRF) as well. In the cat, electrolytic lesions ofthe NRM (Morton et al., 1984) or lidocaine blockade of the NRM (Gebhart et al., 1983b) failed to affect the spontaneous or noxious heat-evoked activity of spinal dorsal horn nociceptive neurons. Only when both the NRM and MRF were simultaneously blocked by the local anesthetic lidocaine was the PAG-produced inhibition of noxious heat-evoked spinal neuronal excitation affected (Gebhart et al., 1983b) . In a recent study in the lightly pentobarbital-anesthetized rat, the MRF was also shown to serve as an important bulbar relay between the midbrain and the spinal cord (Sandktiler and Gebhart, 1984b) . Not until the NRM and both adjacent MRFs were simultaneously blocked by lidocaine was the descending inhibition of the nociceptive tail flick (TF) reflex produced by electrical stimulation in the PAG affected (Sandkiihler and Gebhat-t, 1984b) . Anatomically, Beitz et al. (1983a) have shown that projections to the NRM and MRF arise from separate but adjacent neurons in the PAG of the rat. It had been previously thought that PAG efferents to the NRM sent collaterals to the MRF (Basbaum and Fields, 1978; Fields and Basbaum, 1978) . These studies suggest that excitation of the PAG may activate multiple, perhaps independent, systems of descending inhibition.
The neurotransmitter(s) in the medulla mediating PAG-produced descending inhibition has not been determined. Midbrain efferents to the rostral ventral medulla in the rat have been Vol. 6, No. 6, Jun. 1986 demonstrated to contain enkephalin, serotonin, glutamate, and substance P (e.g., Beitz, 1982; Beitz et al., 1983b; Wiklund et al., 1985; Yezierski et al., 1982) . Electrophysiological studies examining the transmitter in the NRM mediating PAG-produced effects have failed to establish roles for norepinephrine (Behbehani et al., 198 1; Willcockson et al., 1982) , serotonin (Willcockson et al., 1982) or substance P (Pomeroy and Behbehani, 1980) . In the present study, pharmacologic antagonists of serotonin, opioid, and glutamate/aspartate receptors were administered into the medial medullary NRM to block presumptive postsynaptic receptors on bulbospinal neurons mediating descending inhibition of the TF reflex produced by focal electrical stimulation in the PAG. Parts of these data have been presented in abstract form (Dilts and Gebhart, 1984) .
Materials and Methods

Animals
Adult male Sprague-Dawley albino rats (Sasco Inc., Oregon, WI) weighing 250-350 gm on the day of surgery were used in all experiments. Rats were initially anesthetized with 45 mg/kg pentobarbital sodium (Nembutal) given intraperitoneally.
The femoral vein and artery were cannulated and a craniotomy was performed. Following surgery, wound margins were covered with a local anesthetic ointment and a light level ofanesthesia (cornea1 and flexion reflexes present) was maintained thereafter by an intravenous infusion of pentobarbital, 3-6 mg/kg/hr Ossiuov. 1986: Jones and Gebhart. 1986: Sandkiihler and Gebhart, 19849) . Rats were warmed on a heating pad; body temperature (rectal probe) and arterial blood pressure were monitored continuously.
Guide cannulae of 26 gauge (0.46 mm OD) stainless steel tubing were stereotaxically placed in the PAG, NRM, and bilaterally adjacent MRFs to allow both focal electrical stimulation and drug microinjection at the same intracerebral sites. The incisor bar was set at 3.3 mm below the horizontal zero (Paxinos and Watson, 1982) . Coordinates for placement of cannulae in the PAG were 6.5-6.8 mm caudal from the bregma and 0.5 mm lateral to the midline. Coordinates for the NRM were 10.5-11.0 mm caudal from the bregma (on the midline); guide cannulae in the MRF were in the same coronal plane as the NRM and were positioned bilaterally 1.1 mm lateral to the cannula in the NRM and at the identical depth. In all cases, guide cannulae were lowered to 2 mm above the intended site. [See Sandktihler and Gebhart (1984b) for a full account of the placement of cannulae.]
In other animals, a single guide cannula was permanently implanted to a depth 2 mm above an intended site in the NRM for repeated testing of drug-produced effects in the same animal. These guide cannulae (0.46 mm OD; Plastic Products, Roanoke, VA) were permanently affixed to the skull using jeweler's screws and dental acrylic. Experiments were performed on the day of surgery while the rats were lightly anesthetized and also later in the awake state. Drug administration and testing were always separated by at least 2 d.
Noxious stimulation
The nociceptive TF reflex was evoked by focused radiant heat (4 x 10 mm area) applied to the underside of the tail @'Amour and Smith, 194 1). Heat was applied randomly to 6-7 evenly spaced sites along the tail starting 2.5 cm from its distal end. A cut-off time of 7 set was used to minimize damage to the skin of the tail. Following inhibition of the TF reflex by supraspinal focal electrical stimulation, a control TF always followed at the next interval. Noxious heat was applied at 2 min intervals; this paradigm produced stable baseline TF latencies for several hours without damage to the tail (e.g., Gebhart and Ossipov, 1986; Jones and Gebhart, 1986; Sandkilhler and Gebhart, 1984a, b) .
Brain stimulation
Focal electrical brain stimulation of continuous 100 Hz constant-current, 100 psec duration cathodal pulses was used throughout.
Brain stimulation was started 10 set before and continued during noxious heating of the tail until the TF was evoked or 7 set elapsed. This paradigm of stimulation has been determined experimentally to require the lowest intensities of stimulation in the PAG for inhibition of the TF reflex (Sandklihler and Gebhart, 1984a) . Monopolar stimulating electrodes of 34 gauge (0.15 mm OD) insulated magnet wire (toughpitch copper wire; Belden, Geneva, IL) inserted through the 26 gauge guide cannulae were used throughout. The electrodes were cut to extend 2 mm beyond the tip of the guide cannulae. Stimulation intensities were increased until the TF reflex was inhibited or non-antinociceptive effects were noted (increases in blood pressure or muscle flexion/extension). Stimulation intensities did not exceed 200 PA to minimize spread of current (Ranck, 1975) .
Intracerebral microinjections
Microinjections
(0.5 ~1) were made with 33 gauge (0.20 mm OD) injection cannulae inserted into and extending 2 mm beyond the end of the guide cannulae. The injection was delivered over a 1 min period, and the injection cannula was left in place for an additional 1 min to minimize spread of the injectate along the injection track. The progress of the microinjection was continuously monitored by observing the travel of an air bubble in a length of calibrated polyethylene 10 tubing inserted between the injection cannula and a 5 ~1 syringe.
The following drugs and doses (as base) were microinjected into medullary sites: artificial CSF, normal saline, 4% lidocaine (Astrae), naloxone HCl ( 
Experimental groups
Initial experiments were done to establish the efficacy of opioid, serotonergic, and glutaminergic receptor antagonists microinjected in the medulla. After stimulation thresholds for inhibition of the TF reflex were determined to be stable-i.e., 3 consecutive inhibitions of the TF reflex at the same threshold intensity of brain stimulation, each followed by a control TF (see Gebhart and Ossipov, 1986; Jones and Gebhart, 1986; Sandkiihler and Gebhart, 1984b )-microinjection of a receptor antagonist was made at the site of stimulation and its effect on the stimulation threshold (at that site) required to inhibit the TF reflex was determined.
In another group of animals, morphine, serotonin, or normal saline was microinjected into the medulla to assess the antinociceptive efficacy of these receptor agonists. The effect of these drugs on the TF reflex latency was determined at 5, 15, and 30 min after intramedullary administration. Experiments were performed in animals while lightly anesthetized and in the same animals later in the awake state.
A third set of experiments was done to determine the efficacy of opioid and glutaminergic receptor antagonists against morphine and glutamate, respectively. Either morphine or glutamate was microinjected into the medulla in separate experiments, its effect on the TF reflex determined, and a receptor antagonist then microinjected into the same site in the medulla. The ability of the antagonist to reverse the effect of the agonist or to block the effects of agonists subsequently microinjected at the same site was determined.
A final series of experiments was done to determine whether a serotonin, glutamate/aspartate, or an opioid receptor in the NRM mediates inhibition of the TF reflex produced by electrical stimulation in the PAC. Stable thresholds of stimulation for inhibition of the TF reflex were established for all 4 sites of stimulation: PAG, NRM, and both MRFs (see above). To produce a nonspecific functional block, lidocaine (4%) was microinjected into the MRFs bilaterally, and stimulation thresholds in the PAG and NRM were redetermined.
The NRM was then selectively blocked by microinjection ofeither methysergide, naloxone, DGG, or APV. While a functional block was nresent in the MRFs andthe stimulation threshold in the NRM for inhidition of the TF reflex was experimentally established to be increased significantly by the pharmacological antagonist, the stimulation threshold in the PAG for inhibition of the TF reflex was redetermined.
In all cases, the effects of lidocaine and the pharmacologic antagonists microinjected into the medulla were time-limited and reversible. This was established by following the return of stimulation thresholds for inhibition of the TF reflex to pre-microinjection intensities of stimulation.
Histology
At the end of the experiment, rats were sacrificed with an overdose of pentobarbital. Anodal electrolytical lesions (500 PA DC, 3 set) were made to allow for histological verification of stimulation and injection sites in cresyl violet-stained coronal brain sections (40 pm). -150 
Statistical analyses
Statistical comparisons were made using Student's paired t test, twoway analysis of variance, and Newman-Keuls test for multiple comparisons; p 5 0.05 was considered significant. Data are presented as means + SEM.
Results
Before testing the effect of receptor antagonists microinjected into the NRM and, by inference, identifying a neurotransmitter at that bulbar relay mediating PAG-produced descending in- hibition, it was first necessary to characterize the efficacy of appropriate receptor agonists as well as the antagonists microinjetted into the medulla. Thus, agonists and antagonists at opioid, serotonin, substance P, and glutamate/aspartate receptors were microinjected into the medulla and their antinociceptive efficacy, interaction, and effect on focal electrical stimulation in the medulla were examined in initial experiments.
Eficacy of receptor antagonists and agonists microinjected into the medulla In the first series of experiments, the effects of artificial CSF, methysergide, naloxone, lidocaine, and the glutamate/aspartate antagonists, DGG and APV, were examined on stimulation thresholds in the medial medulla for inhibition of the TF reflex. Methysergide, naloxone, lidocaine, DGG, and APV microinjetted into the medulla all significantly increased the stimulation threshold in the medulla for inhibition of the TF reflex (Table  1) . Artificial CSF microinjected into the medulla in the same volume (0.5 rl), however, produced a brief, insignificant increase in the stimulation threshold for inhibition of the TF reflex (Fig.  1) . The mean increases in stimulation threshold ranged from an approximate doubling in threshold (103%) for naloxone to 1200% (lidocaine or methysergide). The effects of the antagonists were time-limited and reversible; the mean durations of increase in stimulation threshold ranged between 30 min (APV) and 74 min (methysergide). (See also Fig. 1 for examples.) A variety of substance P antagonists (o-Pro*@-Phe?,o-Trp9-substance P, D-Argl,~-Pro*,~-Trp~.~,Leu"-substance P, and DProZ,o-Trp7,9-substance P; 2.5 and 5 rcg) were also microinjected into the NRM. In all cases (n = 8), the administration of these agents caused the death of the animal within 13-2 1 min (respiratory failure and cardiovascular collapse). Thus, the role of substance P as a transmitter candidate in the medulla mediating PAG-produced descending inhibition could not be evaluated.
In a second series of experiments, morphine or serotonin was microinjected into the medulla in rats while lightly anesthetized and again 2 d later into the same sites in the same rats while awake. Some animals were subsequently reanesthetized and tested again; in all animals testing was separated by 2 d. The sensitivity of the microinjection site was always confirmed by a final microinjection of 10 pg of morphine into the NRM in the awake state. This dose of morphine was found to be consistent in producing inhibition of the TF reflex if the site of microinjection was undamaged by previous microinjections. The microinjection of morphine into the NRM in doses of 2.5, 5, or IO pg significantly increased TF latencies in a dose-dependent manner in the same animals in both the lightly anesthetized and awake states (Fig. 2) . Morphine was more potent, however, in awake rats; the antinociception produced by all 3 doses of morphine in awake rats was greater than that produced in the same rats while lightly anesthetized (Fig. 20) .
The microinjection of serotonin into the NRM at doses of 5 or 10 pg did not affect the latency of the TF reflex at any time tested in either the awake or anesthetized state (Fig. 3) . Similarily, at no time following its microinjection did normal saline affect the latency of the TF reflex in either awake or anesthetized rats. It should be noted that the control TF latency while lightly anesthetized was significantly shorter than the TF latency in the same rats when tested while awake. The mean TF latencies of the 35 pairs of rats described in Figures 2 and 3 were 2.10 f 0.06 and 2.38 f 0.05 set, respectively, for lightly anesthetized and awake animals (t = 3.0547; p < 0.005). This confirms earlier results from this laboratory (Sandktihler and Gebhart, 1984a) suggesting that light pentobarbital anesthesia releases the TF reflex from tonic descending inhibition, resulting in a relative hyperalgesia. Glutamate (100 mM, 0.5 ~1) microinjected into the ventral medulla produced an inhibition of the TF reflex. The duration of this inhibition was 5.06 f 1.55 min, after which the TF reflex latencies returned to control (Fig. 4A) . Sites in the medulla at which inhibition of the TF reflex produced by glutamate was blocked or attenuated by the putative glutamate receptor antagonists APV or DGG are shown in Figure 4B as an example. In 9 experiments, glutamate was microinjected into the medulla, producing inhibition of the TF reflex. After TF reflex latencies had returned to control, APV (5 Kg) or DGG (1 pg) was microinjected into the same site in the medulla followed by a second microinjection of glutamate into the same site. In 9/9 instances, the effects of glutamate were blocked or attenuated significantly by the prior administration of either APV or DGG (see example in Fig. 4B ). To assure that microinjection of glutamate did not render the injection site insensitive to subsequent microinjections of glutamate, thus suggesting an efficacy for DGG or APV that neither possesses, glutamate microinjections were made twice into the same site in a different group of rats. In 5/5 cases, glutamate produced inhibition of the TF reflex following a second microinjection (see example in Fig. 4A ), the duration of which was equal to that of inhibition produced by the initial microinjection of glutamate (these 5 sites are also shown in Fig. 4B) .
In Figure 4C , sites at which the microinjection of morphine (10 Fg) into the medulla produced an inhibition of the TF reflex that was subsequently reversed by the microinjection of nalox- v one (10 or 20 pg) at the same site are shown; an example is also given. In all cases in which morphine produced an inhibition of the TF reflex, the subsequent microinjection of naloxone reversed morphine's effect and returned the TF reflex latencies to control values.
PAG stimulation and medullary blockade
The foregoing experiments establish that opioid and glutamate receptors in the NRM, when acted on by an appropriate agonist, produce a pharmacologically reversible inhibition of the TF reflex (i.e., an antinociception). In the final set of experiments, the effects of the opioid receptor antagonist naloxone, the serotonin receptor antagonist methysergide, and the glutamate receptor antagonists DGG and APV microinjected into the NRM were tested for their efficacy against stimulation-produced inhibition of the TF reflex from the PAG. Stable stimulation thresholds for inhibition of the TF reflex were established in the PAG, NRM, and bilaterally in the MRFs. Lidocaine was then microinjected into the MRFs bilaterally at 2 sites per side 1 mm apart dorsoventrally to produce a complete functional block of laterally descending pathways. The spread of lidocaine (4%, 0.5 ~1) and the duration of its effect when employed in this fashion have been previously determined (Sandktihler and Gebhart, 1984b) . After the microinjections of lidocaine, stimulation thresholds for inhibition of the TF reflex in the PAG and NRM were experimentally established as unchanged. A selected receptor antagonist or lidocaine was then microinjected into the NRM at 2 sites 1 mm apart dorsoventrally. While all medullary sites of microinjectiotistimulation were blocked by lidocaine (MRFs) and lidocaine or a receptor antagonist (NRM), the stimulation threshold in the PAG for inhibition of the TF reflex was determined, following which the stimulation thresholds for inhibition of the TF reflex from all 3 sites in the medulla were redetermined. Only experiments in which stimulation thresholds at all 3 sites in the brain stem could be experimentally tested following drug microinjection were included in the data analysis. It was determined in the first series of experiments (Table 1 ) that the microinjection of lidocaine or the selected receptor antagonists produced a significant increase in stimulation thresholds; therefore, experiments in which significant increases in stimulation thresholds in the medulla were not produced were also not included in the data analysis (n = 4).
The data from these experiments are summarized in Table 2 and Figure 5 . When the rostral ventral medullary NRM and MRFs bilaterally were blocked simultaneously with lidocaine, the stimulation threshold in the PAG for inhibition of the TF reflex increased significantly: 143.2 + 18.2% (Pig. 54). Microinjection of methysergide or naloxone into the NRM when the MRFs bilaterally were blocked simultaneously with lidocaine failed to affect the intensity of stimulation in the PAG required to inhibit the TF reflex: 5.0 + 5.00/6 and 9.0 f 5.5% increases in threshold, respectively (Fig. 5 , B, C'). Microinjection of the putative nonselective glutamate/aspartate antagonist (Sawada and Yamamoto, 1984) DGG into the NRM when the MRFs were simultaneously blocked bilaterally with lidocaine significantly increased the stimulation threshold in the PAG required to inhibit the TF reflex: 70.1 + 12.1% (Fig. 5E ). The putative selective N-methyl-D-aspartate (NMDA) antagonist (Foster and Fagg, 1984) APV was employed to confirm the effects produced by DGG; APV also increased significantly the stimulation threshold in the PAG: 82.1 + 6.9O~'o (Fig. 5D) . In 2 experiments, lidocaine and DGG were both microinjected dorsal to the MRFs and NRM, respectively. These microinjections caused significant increases in stimulation thresholds at the medullary sites of microinjection, but the PAG stimulation threshold for inhibition of the TF reflex remained unchanged (Fig. SF,) , thus confirming the specificity of the site of effect. In 4 additional experiments, DGG and APV were microinjected into 2 sites 1 mm apart dorsoventrally in the NRM as described above, but the adjacent MRFs were not blocked by lidocaine. The stimulation threshold in the PAG for inhibition of the TF reflex was unchanged in these experiments: 55.0 * 5.0 PA vs 57.5 + 4.8 PA before and after microinjection in the NRM, respectively. receptor selectivity of the effects observed is supported by the failure of either naloxone or methysergide to affect the PAG stimulation threshold for inhibition of the TF reflex. It was also confirmed in these studies that agonist interaction at opioid or glutamate receptors in the medulla activates descending inhibition of the TF reflex. Electrophysiological investigations have established that stimulation in the PAG evokes a short-latency response in neurons in the NRM (Fields and Anderson, 1978; Mason et al., 1985; Pomeroy and Behbehani, 1979; Vanegas et al., 1984; Willcockson et al., 1982) . Vanegas et al. (1984) recently reported that 85% of 31 neurons in the rostra1 ventromedial medulla increased activity during PAG stimulation at intensities sullicient to inhibit the TF reflex. Behbehani and Fields (1979) The medullary reticular formation bilaterally was blocked simultaneously with lidocaine (see text for additional information). Data are reported as means ? SEM. Asterisks denote significant difference from respective predrug threshold, p 5 0.05 (Student's paired t test). E All intramedullary microinjections were given in two sites, 1 mm apart dorsoventrally, in volumes of 0.5 ~1 each (see Fig. 5 ).
h Putative glutamate receptor antagonists m.-2-amino-S-phosphonovalerate (APV) and y-D-glutamylglycine (DGG). Vol. 6, No. 6, Jun. 7986 ported earlier that excitation of cells in the PAG by the microinjection of glutamate is correlated with an increased firing of cells in the NRM and is also associated with elevation of a flexion reflex threshold. They concluded that an excitatory connection between the PAG and NRM, when activated, produces an antinociception. More recently, Mason et al. (1985) reported that sites of electrical stimulation in the PAG that suppress the jaw-opening reflex evoke monosynaptic postsynaptic potentials in pontomedullary neurons, thus supporting the hypothesis that stimulation-produced effects from the PAG are mediated, at least in part, through the direct activation of neurons in the NRM. The foregoing establishes electrophysiologically the excitatory connection from the PAG to the NRM, anatomical evidence also has been provided recently. By mapping amino acid afferents to the NRM autoradiographically, Wiklund et al. (1985) identified a connection between the PAG and NRM in which glutamate/aspartate serves as the neurotransmitter. This anatomical evidence further supports the present results that descending inhibition produced by focal electrical stimulation in the PAG is mediated by glutamate/aspartate released in the NRM.
Establishing a role for glutamate as an excitatory neurotransmitter in the CNS has been hampered by its presence as an intermediate in neuronal metabolism. Biochemical and electrophysiological investigations, however, have satisfied many of the criteria for establishment ofglutamate as a neurotransmitter (Fonnum, 1984; Johnson, 1978; Watkins and Evans, 1981) . Precursors for its synthesis and metabolizing enzymes have been demonstrated in the CNS (Hamberger et al., 1979a, b) . Glutamate also is taken up into synaptic vesicles in a Na+-dependent manner, and on depolarization its release is Ca*+-dependent (Fonnum, 1984) . Studies employing lesion techniques further support a role for glutamate as a transmitter in the hippocampus, olfactory bulb, cerebellum, and other areas (Watkins and Evans, 198 1) . Saturable and reversible binding sites for glutamate also have been found to be unevenly distributed throughout the brain; binding is most prominent in hippocampus and cortex, areas reflecting putative glutaminergic pathways (Greenamyre et al., 1984) . This binding has a Kd in the high nanomolar range with a &,, of approximately 15 pmol/mg protein (Fagg and Matus, 1984; Greenamyre et al., 1984) . The varying potency and efficacy of a variety of glutamate agonists have led to the proposal that there exist multiple excitatory amino acid receptor subtypes (see Foster and Fagg, 1984; and Watkins and Evans, 1981 , for review). Unfortunately, an antagonist able to distinguish between receptor binding by glutamate and aspartate has not been developed. That glutamate or aspartate is the excitatory neurotransmitter linking the PAG and the NRM in the production of descending inhibition has not been previously demonstrated. While present in low levels as compared to the hippocampus, glutamate binding also is seen in the PAG and in the NRM (Greenamyre et al., 1984) . The present data indicate that these glutamate binding sites in the NRM may play a functional role in descending inhibition arising from the PAG.
There have been previous investigations of the contribution of medullary structures to descending inhibition from the PAG (e.g., Behbehani and Fields, 1979; Gebhart et al., 1983b; Llewelyn et al., 1984; Mohrland et al., 1982; Morton et al., 1984; Prieto et al., 1983; Sandkiihler and Gebhart, 1984b) . Most studies have focused on the NRM in the rostra1 ventral medulla. Behbehani and Fields (1979) reported that lesions in the NRM and an area approximately 500 pm in diameter next to this nucleus were effective in blocking the antinociceptive effect of glutamate given in the PAG. Recently, Prieto et al. (1983) reported a high positive correlation between the percentage of NRM destroyed and the percentage increase in the stimulation threshold in the ventral PAG for inhibition of the TF reflex.
While the NRM undeniably plays a role in descending inhibition from the midbrain, the weight of evidence argues against a central, exclusive role for the NRM. Morton et al. (1984) and Gebhart et al. (1983b) have established that inhibition of spinal dorsal horn nociceptive neurons produced by stimulation in the PAG is unaffected by either electrolytic lesions or revisible lidocaine block of the NRM, respectively. It was determined, rather, that both the medial and lateral ventral medulla were important bulbar relays between the PAG and spinal cord (Gebhart et al., 1983b) . Later, Sandktihler and Gebhart (1984b) demonstrated that a local anesthetic block of the medial and lateral ventral medulla simultaneously by lidocaine is required to increase significantly the stimulation threshold in the PAG for inhibition of the TF reflex. It was considered in the present study that if relevant receptors in the NRM were blocked selectively by a receptor antagonist while the MRFs were simultaneously nonselectively blocked with lidocaine, the neurotransmitter(s) in the medial medulla, functionally important to descending inhibition produced by stimulation in the midbrain, could be determined. The stimulation threshold in the PAG for inhibition of the TF reflex was increased significantly only following microinjection of lidocaine, DGG, or APV into the NRM, naloxone and methysergide were ineffective.
Conflicting results concerning the role of serotonin as the neurotransmitter in the medial medullary NRM, however, have been reported by Llewelyn et al. (1984) . Following the microinjection of methysergide (5 pg) into the NRM, they observed a complete block of the antinociception (inhibition of the TF reflex) produced by stimulation in the PAG. However, they observed no change in PAG-produced antinociception following either microinjection of a different serotonin receptor antagonist (cinanserin) or the local anesthetic tetracaine. It is possible that the large microinjection volume (2 ~1) employed was sufficient to produce a block of both medial and lateral brain-stem sites. There was apparently no verification of either the efficacy or spread of methysergide or tetracaine, and it is not clear at present why only methysergide, but neither cinanserin nor tetracaine, was found to be efficacious in their experiments (Llewelyn et al., 1984) . Lovick (1985) recently reported that bilateral electrolytic lesions in the rostra1 ventrolateral medulla abolished both the antinociceptive and cardiovascular effects produced by electrical stimulation in the PAG. These results are concluded to be at variance with the work of Sandkiihler and Gebhart (1984b) and also with results repeated here-due to the different general anesthetic used (Saffan) and the longer control TF reflex latencies (2.5-3.5 see). There is, however, a more significant experimental variable likely contributing to the divergent results. In both the present and earlier study (Sandkiihler and Gebhart, 1984b) , the intensity of supraspinal stimulation in the PAG required to inhibit the TF reflex was the dependent variable measured. In the study by Lovick (1985) the dependent variable was the measure of antinociceptive and cardiovascular effects produced by a jxed intensity of electrical stimulation in the PAG. The inhibitory intensity of focal electrical stimulation often increases slightly before stabilizing (e.g., Ossipov, 1986, Jones and Gebhart, 1986; Sandktihler and Gebhart, 1984a) ; thus, the experimental criterion employed here and elsewhere (Gebhart and Ossipov, 1986; Jones and Gebhart, 1986; Sandkiihler and Gebhart, 1984a) is that the TF reflex must be inhibited three times consecutively by the same intensity of stimulation (each followed by a control TF in the absence of supraspinal stimulation) before that intensity is identified as the inhibitory threshold. In other experiments where the effects of receptor antagonists administered into the spinal intrathecal space were examined on supraspinal stimulation-produced inhibition of the TF reflex, the intensity of stimulation for inhibition of the TF reflex always increased slightly, perhaps due to nonspecific changes produced by dru8 injection (Gebhart and Ossipov, 1986; Jones and Gebhart, 1986) . So too did both naloxone and methysergide in the present study produce slight, insignificant increases in the stimulation threshold in the PAG. Thus, the intensity of stimulation in the PAG has been routinely used as the dependent variable in this laboratory. It is not known in the study of Lovick (1985) whether increasing the intensity of stimulation in the PAG would have overcome the effect of the electrolytic lesions or whether changes in lesion size, local edema, or bleeding, etc., could have contributed to the results. Unfortunately, it is not possible to evaluate functionally the extent of area influenced by electrolytic lesions during the course of an experiment (as one can with a local anesthetic block).
There is a substantial and somewhat confusing literature regarding antagonism by naloxone of stimulation-produced antinociception (SPA) from the PAG. Many investigators have reported that the systemic administration of naloxone significantly attenuates SPA (e.g., Adams, 1976; Akil et al., 1976; Hosobuchi et al., 1977) , while others have failed to observe an effect of naloxone (e.g., Gebhart and Toleikis, 1978; Pert and Walter, 1976; Yaksh et al., 1976) . Recently, Cannon et al. (1982) reported that naloxone antagonizes SPA from the ventral, but not dorsal, PAG, suggesting that qualitatively different forms of SPA can be evoked from the midbrain and perhaps clarifying some of the confusion in the literature regarding naloxone's efficacy. Neither in the present nor related studies, however, was a difference observed either in inhibitory efficacy or susceptibility to medullary manipulations among electrodes placed dorsoventrally in the PAG (Gebhart et al., 1983a; Morton et al., 1984; Sandkiihler and Gebhart, 1984a, b; see, however, Prieto et al., 1983) . In this and another study (Llewelyn et al., 1984) , the inability of naloxone to increase significantly the stimulation threshold in the PAG for inhibition of the TF reflex indicates that the locus of naloxone's action is not at the level of the bulbar relay between the PAG and the spinal cord. Further, the intrathecal administration of naloxone also is unable to block SPA from the PAG (Aimone et al., 1986) . Thus, naloxone's antagonism of SPA from the PAG likely occurs supraspinally. That an endogenous opioid is not the transmitter of the PAG-NRM connection also is supported anatomically (Beitz, 1982) . Using a combined retrograde HRP immunohistochemical procedure, very few enkephalin (and substance P)-containing fibers from the PAG to the NRM were observed in the rat. In an electrophysiological study by Pomeroy and Behbehani (1980) , the iontophoretic application of substance P onto neurons in the NRM was compared to the response of those same neurons to focal stimulation in the PAG. Using this method, they failed to establish a role for substance P in the NRM. In the present study various substance P antagonists were tried, but all produced death on microinjection into the NRM. Ossipov and Gebhart (1984) reported that light pentobarbital anesthesia in rats shifts the antinociceptive dose-response curve for morphine administered into the PAG to the right. They concluded that it is likely that pentobarbital anesthesia depresses the descending inhibitory pathway(s) activated by morphine administered into the PAG. The present study examined in a similar fashion the effects of light pentobarbital anesthesia on the inhibition of the TF reflex produced by morphine microinjetted into the NRM. Morphine was found to be more potent in awake than lightly anesthetized rats, a result similar to that found following the intra-PAG administration of morphine (Ossipov and Gebhart, 1984) . While a greater potency was seen in awake rats, the difference in the potency of morphine between the awake and anesthetized states was less dramatic in the present than previous study. It is possible that the depression produced by pentobarbital has less effect on the descending systems influenced by morphine administered into NRM, perhaps because morphine's influence in the NRM activates a single system of descending inhibition while morphine microinjected into the PAG activates multiple systems of descending inhibition.
In contrast to morphine, serotonin was without effect on the TF reflex when microinjected into the NRM in either awake or lightly anesthetized rats. This result conflicts with a report that 5 Kg serotonin microinjected into the NRM inhibited the TF reflex but not a paw-withdrawal reflex (Llewelyn et al., 1983) . The result may be related to the large volume of microinjection (2 ~1) and production, for example, of a nonspecific mechanical effect. It has been recommended that 0.5 ~1 is the largest volume that should be microinjected intracerebrally into rat brain to limit the influence of distant sites (Myers, 1966) . The volume of the microinjection notwithstanding, it is difficult to understand how serotonin microinjected into the NRM could activate a system of descending inhibition. Inhibitory serotonin autoreceptors have been demonstrated on serotonin-containing neurons (Aghajanian and Wang, 1978) in the CNS, an observation consistent with the inhibition, not excitation, of raphe-spinal neurons by serotonin. Wessendorf and Anderson (1983) reported that serotonergic raphe-spinal neurons in the NRM were inhibited (83% of 30 neurons) by the direct iontophoretic application of serotonin. Similarly, Willcockson et al. (1982) reported that both the glutamate-evoked excitation (29 of 3 1) and spontaneous activity (5 of 6) of raphe-spinal neurons were inhibited by the iontophoretic application of serotonin. Further, serotonin iontophoresed onto 12 raphe-spinal neurons inhibited the increase in neuronal activity of 7 cells produced by electrical stimulation in the PAG (Willcockson et al., 1982) . Based on these considerations, one would not expect serotonin microinjections into the NRM either to excite raphe-spinal neurons or to produce an antinociception.
Glutamate is generally held to nonselectively excite only cell bodies (Goodchild et al., 1982; Johnson, 1972) . Glutamate microinjected into the PAG or NRM will inhibit the TF reflex (Behbehani and Fields, 1979; Jensen and Yaksh, 1984; Satoh et al., 1983; Urea et al., 1980 ; e.g., see Fig. 4A ), but this does not allow one to determine if it is acting selectively at glutamate receptors or nonspecifically exciting cell bodies. That the antagonists DGG and APV were able to block or significantly attenuate the effects of glutamate microinjected into the NRM suggests that glutamate inhibits the TF reflex at least partly through an action at specific glutamate receptors. The putative glutamateiaspartate receptor antagonist DGG has been shown to suppress depolarizations induced by L-aspartate, D-L homocysteate, or L-glutamate (Sawada and Yamamoto, 1984) , while APV has been shown to act relatively selectively at the NMDA glutamate receptor (Foster and Fagg, 1984) . The use of these receptor antagonists does not allow us to distinguish between the 2 excitatory amino acids glutamate and aspartate. Yet similar results with 2 different glutamate/aspartate antagonists, and the lack of effect of DGG microinjected dorsal to the NRM, support our conclusion that an excitatory amino acid is a transmitter candidate in the medial rostra1 ventral medulla mediating descending inhibition produced by focal electrical stimulation in the midbrain PAG. DGG and APV increased the stimulation threshold in the PAG somewhat less than did complete block of the NRM with lidocaine (70 and 82% increase in threshold vs 143% increase, respectively). This difference may be doserelated, but we found essentially equivalent effects of DGG and APV at doses of 1 and 5 pg.Thus, it is likely that a neurotransmitter(s) other than either glutamate or aspartate is also involved in the bulbar relay that mediates descending inhibition from the midbrain. Alternatively, direct spinopetal fibers from the PAG may have been unaffected by either DGG or APV but would have been blocked with lidocaine (e.g., see Manthy and
